Since immune cells express DAT and TH, and that CNS dopamine neurons expressing the same markers are decreased in PD patients, we next asked whether or not DAT+ and TH+ PBMCs were altered in PD patients compared to healthy controls, and whether disease duration, sex, age, treatments, and comorbid conditions affect these measures. The gene discussed is SLC6A3; the disease is Parkinson disease.